115 related articles for article (PubMed ID: 21240562)
1. Risk factors, prognosis, and management of early and late intrahepatic recurrence after resection of primary clear cell carcinoma of the liver.
Li T; Fan J; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY
Ann Surg Oncol; 2011 Jul; 18(7):1955-63. PubMed ID: 21240562
[TBL] [Abstract][Full Text] [Related]
2. Prognosis and results after resection of very large (>or=10 cm) hepatocellular carcinoma.
Shah SA; Wei AC; Cleary SP; Yang I; McGilvray ID; Gallinger S; Grant DR; Greig PD
J Gastrointest Surg; 2007 May; 11(5):589-95. PubMed ID: 17393258
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of peritoneal recurrence and outcome of resected peritoneal recurrence after liver resection in hepatocellular carcinoma: review of 1222 cases of hepatectomy in a tertiary institution.
Kow AW; Kwon CH; Song S; Shin M; Kim JM; Joh JW
Ann Surg Oncol; 2012 Jul; 19(7):2246-55. PubMed ID: 22402812
[TBL] [Abstract][Full Text] [Related]
4. Distinct Recurrence Risk Factors for Intrahepatic Metastasis and Multicenter Occurrence After Surgery in Patients with Hepatocellular Carcinoma.
Hao S; Fan P; Chen S; Tu C; Wan C
J Gastrointest Surg; 2017 Feb; 21(2):312-320. PubMed ID: 27815759
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.
Jung SM; Kim JM; Choi GS; Kwon CHD; Yi NJ; Lee KW; Suh KS; Joh JW
J Gastrointest Surg; 2019 Feb; 23(2):304-311. PubMed ID: 30215196
[TBL] [Abstract][Full Text] [Related]
6. The effect of alkaline phosphatase and intrahepatic metastases in large hepatocellular carcinoma.
Kim JM; Kwon CH; Joh JW; Park JB; Ko JS; Lee JH; Kim SJ; Park CK
World J Surg Oncol; 2013 Feb; 11():40. PubMed ID: 23432910
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors and 10-year survival in patients with hepatocellular carcinoma after curative hepatectomy.
Kim SH; Choi SB; Lee JG; Kim SU; Park MS; Kim DY; Choi JS; Kim KS
J Gastrointest Surg; 2011 Apr; 15(4):598-607. PubMed ID: 21336497
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological determinants of survival after hepatic resection of hepatocellular carcinoma in 97 patients--experience from an Australian hepatobiliary unit.
Chua TC; Saxena A; Chu F; Liauw W; Zhao J; Morris DL
J Gastrointest Surg; 2010 Sep; 14(9):1370-80. PubMed ID: 20585991
[TBL] [Abstract][Full Text] [Related]
9. Liver resection for large and huge hepatocellular carcinoma: Predictors of failure, recurrence patterns, and prognoses.
Xiang C; Xiao Y; Ma Z; Peng Y; Li X; Mao X; Li L
Asia Pac J Clin Oncol; 2023 Apr; 19(2):e60-e70. PubMed ID: 35404506
[TBL] [Abstract][Full Text] [Related]
10. Early Versus Late Recurrence of Hepatocellular Carcinoma After Surgical Resection Based on Post-recurrence Survival: an International Multi-institutional Analysis.
Wei T; Zhang XF; Bagante F; Ratti F; Marques HP; Silva S; Soubrane O; Lam V; Poultsides GA; Popescu I; Grigorie R; Alexandrescu S; Martel G; Workneh A; Guglielmi A; Hugh T; Lv Y; Aldrighetti L; Pawlik TM
J Gastrointest Surg; 2021 Jan; 25(1):125-133. PubMed ID: 32128681
[TBL] [Abstract][Full Text] [Related]
11. Early Recurrence of Neuroendocrine Liver Metastasis After Curative Hepatectomy: Risk Factors, Prognosis, and Treatment.
Zhang XF; Beal EW; Chakedis J; Lv Y; Bagante F; Aldrighetti L; Poultsides GA; Bauer TW; Fields RC; Maithel SK; Marques HP; Weiss M; Pawlik TM
J Gastrointest Surg; 2017 Nov; 21(11):1821-1830. PubMed ID: 28730354
[TBL] [Abstract][Full Text] [Related]
12. Preoperative Predictors Including the Role of Inflammatory Indices in Predicting Early Recurrence After Re-resection for Recurrent Hepatocellular Carcinoma.
Guo Y; Chua DW; Koh YX; Lee SY; Cheow PC; Kam JH; Teo JY; Chow PK; Chung AY; Ooi LL; Chan CY; Goh BKP
World J Surg; 2019 Oct; 43(10):2587-2594. PubMed ID: 31222641
[TBL] [Abstract][Full Text] [Related]
13. Management of intrahepatic recurrence after resection for hepatocellular carcinoma exceeding the barcelona clinic liver cancer criteria.
Xu W; Guo R; Xu G; Sun L; Hu D; Xu H; Yang H; Sang X; Lu X; Mao Y
Oncotarget; 2017 Dec; 8(66):110406-110414. PubMed ID: 29299157
[TBL] [Abstract][Full Text] [Related]
14. Role of operative therapy in non-cirrhotic patients with metastatic hepatocellular carcinoma.
Zaydfudim V; Smoot RL; Clark CJ; Kendrick ML; Que FG; Farnell MB; Nagorney DM
J Gastrointest Surg; 2012 Aug; 16(8):1516-23. PubMed ID: 22644447
[TBL] [Abstract][Full Text] [Related]
15. Detailed analysis of recurrent sites after wedge resection for primary hepatocellular carcinoma considering the potential usefulness of anatomic resection: a retrospective cohort study.
Hokuto D; Yasuda S; Kamitani N; Matsuo Y; Doi S; Sho M
Langenbecks Arch Surg; 2023 Jan; 408(1):29. PubMed ID: 36640194
[TBL] [Abstract][Full Text] [Related]
16. Dynamic risk profiling of HCC recurrence after curative intent liver resection.
Ivanics T; Murillo Perez CF; Claasen MPAW; Patel MS; Morgenshtern G; Erdman L; Shwaartz C; Rajendran L; O'Kane GM; Hansen BE; Cleary SP; Sapisochin G
Hepatology; 2022 Nov; 76(5):1291-1301. PubMed ID: 35178739
[TBL] [Abstract][Full Text] [Related]
17. Multidisciplinary management of recurrent hepatocellular carcinoma following liver transplantation.
Kneuertz PJ; Cosgrove DP; Cameron AM; Kamel IR; Geschwind JF; Herman JM; Pawlik TM
J Gastrointest Surg; 2012 Apr; 16(4):874-81. PubMed ID: 21975686
[TBL] [Abstract][Full Text] [Related]
18. Recurrence Pattern Is an Independent Surgical Prognostic Factor for Long-Term Oncological Outcomes in Patients with Hepatocellular Carcinoma.
Hsu HY; Tang JH; Huang SF; Huang CW; Lin SE; Huang SW; Lee CW; Wu TH; Yu MC
Biomedicines; 2024 Mar; 12(3):. PubMed ID: 38540268
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of primary clear cell carcinoma of the liver based on Faster region-based convolutional neural network.
Liu B; Li J; Yang X; Chen F; Zhang Y; Li H
Chin Med J (Engl); 2023 Nov; 136(22):2706-2711. PubMed ID: 37882066
[TBL] [Abstract][Full Text] [Related]
20. Smoking as a Risk Factor for Very Late Recurrence in Surgically Resected Early-Stage Primary Hepatocellular Carcinoma.
Cho WR; Wang CC; Tsai MJ; Lin CC; Yen YH; Chen CH; Kuo YH; Yao CC; Hung CH; Huang PY; Liu AC; Tsai MC
Clin Med Insights Oncol; 2024; 18():11795549241228232. PubMed ID: 38450293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
